Market Cap 2.46B
Revenue (ttm) 15.36M
Net Income (ttm) -276.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,800.00%
Debt to Equity Ratio 0.00
Volume 2,017,000
Avg Vol 3,116,524
Day's Range N/A - N/A
Shares Out 191.59M
Stochastic %K 73%
Beta 1.74
Analysts Strong Sell
Price Target $20.83

Company Profile

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGa...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 370 8837
Address:
60 Hampshire Street, Cambridge, United States
Monkey7779192
Monkey7779192 May. 12 at 11:34 PM
$RLAY Data on May 19 a big mover?
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 2:26 PM
$RLAY Current Stock Price: $12.78 Contracts to trade: $13.0 RLAY May 15 2026 Call Entry: $0.10 Exit: $0.15 ROI: 47% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MorganHoratio
MorganHoratio May. 8 at 1:44 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: PayPay Corp (Tokyo-listed) - 3,125,000 $PL - 35,248,893 $PRME - 16,562,498 $RLAY - 1,564,173 $RVMD - 3,292,525 $SANA - 2,812,500 Google’s Q1 13F is here: Fintech, Real-time Earth, and Gene Editing! The 3.1M share stake in PayPay is a major power move into the East Asian payment ecosystem. Meanwhile, holding 35M shares of $PL (Planet Labs) signals that Google is weaponizing satellite data to give Gemini AI a "God’s eye view" of global logistics. Heavy bets on $PRME and $RVMD also prove that AI-driven oncology and gene editing are now core to Alphabet’s "Other Bets." Do you think the synergy between satellite data and fintech will lead to a breakthrough in 2026? Which of these strategic pivots are you most bullish on?
1 · Reply
BigDaddyCapital
BigDaddyCapital May. 7 at 5:05 PM
$RLAY is everybody just ignoring vascular malformations data and market basically saying no way they compete with CELC? They will likely beat on mutant from tolerability standpoint already received BTD
1 · Reply
Merlintrader
Merlintrader May. 6 at 10:48 AM
$ADPT $SUPN, $RLAY : Three Q1 2026 Earnings Reports, Three Different Biotech Risk Profiles https://www.merlintrader.com/supn-rlay-adpt-three-q12026-earnings/
0 · Reply
AbovetheGreenLine
AbovetheGreenLine May. 5 at 6:00 PM
Discovered that $RLAY has Earnings after the Close today... FYI, if u don't like to be in... https://abovethegreenline.com/wp-content/uploa
0 · Reply
AbovetheGreenLine
AbovetheGreenLine May. 4 at 7:03 PM
Swing Trade Buy on the Close for Relay Thera. $RLAY. https://abovethegreenline.com/wp-content/uploads/2021/01/ST-1.jpg https://zpr.io/YBxXf
0 · Reply
BigDaddyCapital
BigDaddyCapital May. 4 at 2:41 PM
$RLAY CELC will lose mutant long term to relay due to tolerability and possibly efficacy
0 · Reply
Lastaccountgotbannedd
Lastaccountgotbannedd May. 4 at 2:11 PM
$RLAY I’ll probably start scooping up shares here soon
0 · Reply
apeemcape
apeemcape May. 4 at 1:45 PM
$RLAY Biotrash
0 · Reply
Latest News on RLAY
Relay Therapeutics Transcript: Study result

Apr 27, 2026, 8:30 AM EDT - 16 days ago

Relay Therapeutics Transcript: Study result


Relay Therapeutics initiated with a Hold at JonesResearch

2026-04-13T20:12:08.000Z - 4 weeks ago

Relay Therapeutics initiated with a Hold at JonesResearch


Relay Therapeutics  reports Q4 EPS (32c), consensus (39c)

2026-02-26T21:54:34.000Z - 2 months ago

Relay Therapeutics reports Q4 EPS (32c), consensus (39c)


Relay Therapeutics announces analysis of data for zovegalisib

2025-12-12T12:05:20.000Z - 5 months ago

Relay Therapeutics announces analysis of data for zovegalisib


Relay Therapeutics reports Q3 EPS (43c), consensus (42c)

2025-11-06T22:01:35.000Z - 6 months ago

Relay Therapeutics reports Q3 EPS (43c), consensus (42c)


Relay Therapeutics Transcript: Study Update

Dec 11, 2024, 7:00 AM EST - 1 year ago

Relay Therapeutics Transcript: Study Update


Relay Therapeutics Transcript: Study Update

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Relay Therapeutics Transcript: Study Update


Relay Therapeutics Transcript: Status Update

Jun 6, 2024, 8:00 AM EDT - 2 years ago

Relay Therapeutics Transcript: Status Update


Monkey7779192
Monkey7779192 May. 12 at 11:34 PM
$RLAY Data on May 19 a big mover?
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 2:26 PM
$RLAY Current Stock Price: $12.78 Contracts to trade: $13.0 RLAY May 15 2026 Call Entry: $0.10 Exit: $0.15 ROI: 47% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MorganHoratio
MorganHoratio May. 8 at 1:44 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: PayPay Corp (Tokyo-listed) - 3,125,000 $PL - 35,248,893 $PRME - 16,562,498 $RLAY - 1,564,173 $RVMD - 3,292,525 $SANA - 2,812,500 Google’s Q1 13F is here: Fintech, Real-time Earth, and Gene Editing! The 3.1M share stake in PayPay is a major power move into the East Asian payment ecosystem. Meanwhile, holding 35M shares of $PL (Planet Labs) signals that Google is weaponizing satellite data to give Gemini AI a "God’s eye view" of global logistics. Heavy bets on $PRME and $RVMD also prove that AI-driven oncology and gene editing are now core to Alphabet’s "Other Bets." Do you think the synergy between satellite data and fintech will lead to a breakthrough in 2026? Which of these strategic pivots are you most bullish on?
1 · Reply
BigDaddyCapital
BigDaddyCapital May. 7 at 5:05 PM
$RLAY is everybody just ignoring vascular malformations data and market basically saying no way they compete with CELC? They will likely beat on mutant from tolerability standpoint already received BTD
1 · Reply
Merlintrader
Merlintrader May. 6 at 10:48 AM
$ADPT $SUPN, $RLAY : Three Q1 2026 Earnings Reports, Three Different Biotech Risk Profiles https://www.merlintrader.com/supn-rlay-adpt-three-q12026-earnings/
0 · Reply
AbovetheGreenLine
AbovetheGreenLine May. 5 at 6:00 PM
Discovered that $RLAY has Earnings after the Close today... FYI, if u don't like to be in... https://abovethegreenline.com/wp-content/uploa
0 · Reply
AbovetheGreenLine
AbovetheGreenLine May. 4 at 7:03 PM
Swing Trade Buy on the Close for Relay Thera. $RLAY. https://abovethegreenline.com/wp-content/uploads/2021/01/ST-1.jpg https://zpr.io/YBxXf
0 · Reply
BigDaddyCapital
BigDaddyCapital May. 4 at 2:41 PM
$RLAY CELC will lose mutant long term to relay due to tolerability and possibly efficacy
0 · Reply
Lastaccountgotbannedd
Lastaccountgotbannedd May. 4 at 2:11 PM
$RLAY I’ll probably start scooping up shares here soon
0 · Reply
apeemcape
apeemcape May. 4 at 1:45 PM
$RLAY Biotrash
0 · Reply
Quantumup
Quantumup May. 4 at 11:16 AM
Stifel⬆️ $CELC to $150 from $125 and reiterated at a Buy rating. $RLAY $NVS AZN PFE RHHBY BGNE Here's what Stifel had to say in its note to investors: https://x.com/Quantumup1/status/2051258879883764052?s=20
0 · Reply
STACKD0E
STACKD0E May. 2 at 12:02 AM
$LNTH $RLAY 🙃✨️
0 · Reply
apeemcape
apeemcape May. 1 at 7:36 PM
$RLAY Biotrash
0 · Reply
BillionerOfKing
BillionerOfKing May. 1 at 5:58 PM
$RLAY Current Stock Price: $12.91 Contracts to trade: $13.0 RLAY May 15 2026 Call Entry: $0.99 Exit: $1.92 ROI: 94% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
apeemcape
apeemcape May. 1 at 1:18 PM
$RLAY 🐻
0 · Reply
NoRedDays10
NoRedDays10 Apr. 30 at 9:17 PM
$RLAY adding and holding. Seems like a decent entry if drop is profit taking driven.
0 · Reply
apeemcape
apeemcape Apr. 29 at 6:55 PM
$RLAY Biotrash
0 · Reply
apeemcape
apeemcape Apr. 29 at 5:06 PM
$RLAY Biotrash
0 · Reply
apeemcape
apeemcape Apr. 29 at 2:10 PM
$RLAY Biotrash
0 · Reply
apeemcape
apeemcape Apr. 29 at 11:57 AM
$RLAY Biotrash
0 · Reply
DARKP00L
DARKP00L Apr. 29 at 10:52 AM
$RLAY 06:42 on Apr. 29 2026 HC Wainwright & Co. Maintains Buy on Relay Therapeutics, Raises Price Target to $25 #tradeideas
1 · Reply
apeemcape
apeemcape Apr. 29 at 3:26 AM
$RLAY Overbought. Always has been.
2 · Reply